ArticleJAMA2021

Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.

Silje Watterdal Syversen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.